.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Carboplatin - Generic Drug Details

« Back to Dashboard
Carboplatin is the generic ingredient in two branded drugs marketed by Pliva, Mylan Labs Ltd, Hospira, Sun Pharma Global, Pliva Lachema, Actavis Totowa, Fresenius Kabi Oncol, Fresenius Kabi Usa, Teva Pharms Usa, West-ward Pharms Int, Cordenpharma, Sandoz, Cipla Ltd, Watson Labs, Akorn, Pharmachemie Bv, Corden Pharma, Sandoz Inc, Sanja Pharms Co, Teva Parenteral, Nanjing King-friend, and Mylan Institutional, and is included in thirty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for carboplatin. Eight suppliers are listed for this compound.

Summary for Generic Name: carboplatin

Tradenames:2
Patents:0
Applicants:22
NDAs:32
Drug Master File Entries: see list18
Suppliers / Packaging: see list8
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: carboplatin

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
CARBOPLATIN
carboplatin
INJECTABLE;INJECTION076235-003Oct 14, 2004DISCNNo► subscribe► subscribe
Fresenius Kabi Usa
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077247-001Oct 21, 2004DISCNNo► subscribe► subscribe
Fresenius Kabi Usa
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077266-002Feb 15, 2006DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: carboplatin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cordenpharma
PARAPLATIN
carboplatin
INJECTABLE;IV (INFUSION)020452-001Jul 14, 20034,657,927*PED► subscribe
Corden Pharma
PARAPLATIN
carboplatin
INJECTABLE;INJECTION019880-001Mar 3, 19894,657,927*PED► subscribe
Corden Pharma
PARAPLATIN
carboplatin
INJECTABLE;INJECTION019880-002Mar 3, 19894,657,927*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc